National Reference Laboratory (NRL) participated in the 6th Abu Dhabi Brain Conference, held 18–20 September 2026 in Abu Dhabi, showcasing its advanced neurodiagnostic and biomarker testing capabilities.
National Reference Laboratory (NRL) participated in the 6th Abu Dhabi Brain Conference, held 18–20 September 2026 in Abu Dhabi, showcasing its advanced neurodiagnostic and biomarker testing capabilities.
Leading neurologists, researchers and healthcare professionals gathered to explore advances in the diagnosis, treatment and management of neurological disorders.
NRL presented its specialized neurology portfolio, including Alzheimer’s blood biomarkers such as p-Tau 217, reinforcing its commitment to early detection and precision medicine.
